Skip to main navigation Skip to search Skip to main content

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma

  • M. K. Ramirez-Fort
  • , B. Meier-Schiesser
  • , K. Lachance
  • , S. S. Mahase
  • , C. D. Church
  • , M. J. Niaz
  • , H. Liu
  • , V. Navarro
  • , A. Nikolopoulou
  • , D. V. Kazakov
  • , E. Contassot
  • , D. P. Nguyen
  • , J. Sach
  • , L. Hadravsky
  • , Y. Sheng
  • , S. T. Tagawa
  • , X. Wu
  • , C. S. Lange
  • , L. E. French
  • , P. T. Nghiem
  • N. H. Bander

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science